Moreover, PgR is a predictive factor (as depletion of PgR correlates with poor response to megestrol acetate in advanced BC) and a potential target for personalized therapy in BC, either with the use of antiprogestins or, surprisingly, progestogens [29]. This evidence concerns the gene PGR and breast cancer.